Furthermore, our findings demonstrate the crucial role of lncRNA-NUTF2P3-001 mediated translational desuppression in KRAS expression and the therapeutic potential of targeting this pathway in pancreatic cancer. This evidence concerns the gene NUTF2P3 and pancreatic neoplasm.